Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to 1.94%.

  • Cross Country Healthcare's EBITDA Margin fell 27500.0% to 1.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.4%, marking a year-over-year decrease of 12800.0%. This contributed to the annual value of 1.09% for FY2024, which is 46800.0% down from last year.
  • As of Q3 2025, Cross Country Healthcare's EBITDA Margin stood at 1.94%, which was down 27500.0% from 2.43% recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's EBITDA Margin registered a high of 12.11% during Q4 2021, and its lowest value of 4.72% during Q2 2024.
  • Over the past 5 years, Cross Country Healthcare's median EBITDA Margin value was 3.47% (recorded in 2021), while the average stood at 3.09%.
  • Per our database at Business Quant, Cross Country Healthcare's EBITDA Margin surged by 97900bps in 2021 and then plummeted by -86700bps in 2024.
  • Over the past 5 years, Cross Country Healthcare's EBITDA Margin (Quarter) stood at 12.11% in 2021, then plummeted by -52bps to 5.78% in 2022, then crashed by -62bps to 2.19% in 2023, then tumbled by -156bps to 1.23% in 2024, then plummeted by -59bps to 1.94% in 2025.
  • Its EBITDA Margin was 1.94% in Q3 2025, compared to 2.43% in Q2 2025 and 0.17% in Q1 2025.